Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: A decade of research. Comment on Cai et al.: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol. 2011; 227(1): 224-31.

Experimental Neurology

Volumn 231, Issue 1, 2011, Pages 1-10

  Dietz, Gunnar P H ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Antp (antennapedia); Cell penetrating peptide (CPP); Hypoxia; Ischemia; Protein transduction domain (PTD); Stroke; Transactivator of transcription (Tat)

Indexed keywords

APOPTOSIS INDUCING FACTOR; AUTOPHAGY PROTEIN 5; BASIC FIBROBLAST GROWTH FACTOR; CALBINDIN; CELL PENETRATING PEPTIDE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; ERYTHROPOIETIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 91; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISLET BRAIN 1; ISLET BRAIN 2; KALLIKREIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEUROGLOBIN; PEROXIDASE; PROTEIN BCL XL; PROTEIN BNIP3; PROTEIN NOGO A; RIBOSOMAL PROTEIN S3; RIBOSOME PROTEIN; STRESS ACTIVATED PROTEIN KINASE BINDING DOMAIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DRUG ACTIVITY; DRUG EFFICACY; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE REPRESSION; HEART INFARCTION; HEART INJURY; HEART PROTECTION; HUMAN; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; GLOBINS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; NERVE TISSUE PROTEINS; TRANS-ACTIVATORS;

EID: 79961023121     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.05.010     Document Type: Note

References (187)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 2002, 298:846-850.
2. Al-Shabrawey M., Bartoli M., El-Remessy A.B., Platt D.H., Matragoon S., Behzadian M.A., Caldwell R.W., Caldwell R.B. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am. J. Pathol. 2005, 167:599-607.
3. An J.J., Lee Y.P., Kim S.Y., Lee S.H., Lee M.J., Jeong M.S., Kim D.W., Jang S.H., Yoo K.Y., Won M.H., Kang T.C., Kwon O.S., Cho S.W., Lee K.S., Park J., Eum W.S., Choi S.Y. Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J. 2008, 275:1296-1308.
4. Antao S.T., Duong T.T., Aran R., Witting P.K. Neuroglobin overexpression in cultured human neuronal cells protects against hydrogen peroxide insult via activating phosphoinositide-3 kinase and opening the mitochondrial K(ATP) channel. Antioxid. Redox Signal. 2010, 13:769-781.
5. Arakawa M., Yasutake M., Miyamoto M., Takano T., Asoh S., Ohta S. Transduction of anti-cell death protein FNK protects isolated rat hearts from myocardial infarction induced by ischemia/reperfusion. Life Sci. 2007, 80:2076-2084.
6. Asanuma T., Inanami O., Tabu K., Waki K., Kon Y., Kuwabara M. Protection against malonate-induced ischemic brain injury in rat by a cell-permeable peptidic c-Jun N-terminal kinase inhibitor, (L)-HIV-TAT48-57-PP-JBD20, observed by the apparent diffusion coefficient mapping magnetic resonance imaging method. Neurosci. Lett. 2004, 359:57-60.
7. Asoh S., Ohsawa I., Mori T., Katsura K., Hiraide T., Katayama Y., Kimura M., Ozaki D., Yamagata K., Ohta S. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:17107-17112.
8. Astudillo L., Bernad S., Derrien V., Sebban P., Miksovska J. Probing the role of the internal disulfide bond in regulating conformational dynamics in neuroglobin. Biophys. J. 2010, 99:L16-L18.
9. Beltran-Parrazal L., Acuna D., Ngan A.M., Kim E., Ngan A., Kawakami K., Edmond J., Lopez I.A. Neuroglobin, cytoglobin, and transcriptional profiling of hypoxia-related genes in the rat cerebellum after prenatal chronic very mild carbon monoxide exposure (25ppm). Brain Res. 2010, 1330:61-71.
10. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 2003, 9:1180-1186.
11. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 2003, 9:1180-1186.
12. Bright R., Steinberg G.K., Mochly-Rosen D. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res. 2007, 1144:146-155.
13. Brunori M., Giuffre A., Nienhaus K., Nienhaus G.U., Scandurra F.M., Vallone B. Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8483-8488.
14. Brunori M., Vallone B. A globin for the brain. FASEB J. 2006, 20:2192-2197.
15. Bu X., Zhang N., Yang X., Liu Y., Du J., Liang J., Xu Q., Li J. Proteomic analysis of cPKCbetaII-interacting proteins involved in HPC-induced neuroprotection against cerebral ischemia of mice. J. Neurochem. 2011, 117(2):346-356.
16. Burmester T., Gerlach F., Hankeln T. Regulation and role of neuroglobin and cytoglobin under hypoxia. Adv. Exp. Med. Biol. 2007, 618:169-180.
17. Burmester T., Weich B., Reinhardt S., Hankeln T. A vertebrate globin expressed in the brain. Nature 2000, 407:520-523.
18. Cai B., Lin Y., Xue X.H., Fang L., Wang N., Wu Z.Y. TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp. Neurol. 2011, 227:224-231.
19. Calvert J.W., Gundewar S., Yamakuchi M., Park P.C., Baldwin W.M., Lefer D.J., Lowenstein C.J. Inhibition of N-ethylmaleimide-sensitive factor protects against myocardial ischemia/reperfusion injury. Circ. Res. 2007, 101:1247-1254.
20. Cao G., Pei W., Ge H., Liang Q., Luo Y., Sharp F.R., Lu A., Ran R., Graham S.H., Chen J. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 2002, 22:5423-5431.
21. Chang W., Song B.W., Lim S., Song H., Shim C.Y., Cha M.J., Ahn D.H., Jung Y.G., Lee D.H., Chung J.H., Choi K.D., Lee S.K., Chung N., Lee S.K., Jang Y., Hwang K.C. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 2009, 27(9):2283-2292.
22. Chen X.Q., Qin L.Y., Zhang C.G., Yang L.T., Gao Z., Liu S., Lau L.T., Fung Y.W., Greenberg D.A., Yu A.C. Presence of neuroglobin in cultured astrocytes. Glia 2005, 50:182-186.
23. Cheng C.H., di P.G., Verde C. Cold-adapted Antarctic fish: the discovery of neuroglobin in the dominant suborder Notothenioidei. Gene 2009, 433:100-101.
24. Cho J.H., Hwang I.K., Yoo K.Y., Kim S.Y., Kim D.W., Kwon Y.G., Choi S.Y., Won M.H. Effective delivery of Pep-1-cargo protein into ischemic neurons and long-term neuroprotection of Pep-1-SOD1 against ischemic injury in the gerbil hippocampus. Neurochem. Int. 2008, 52:659-668.
25. Chuang P.Y., Conley Y.P., Poloyac S.M., Okonkwo D.O., Ren D., Sherwood P.R., Hravnak M., Alexander S.A. Neuroglobin genetic polymorphisms and their relationship to functional outcomes after traumatic brain injury. J. Neurotrauma 2010, 27:999-1006.
26. Cramer S.C. Repairing the human brain after stroke. II. Restorative therapies. Ann. Neurol. 2008, 63:549-560.
27. Cramer S.C. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann. Neurol. 2008, 63:272-287.
28. Cui H., Hayashi A., Sun H.S., Belmares M.P., Cobey C., Phan T., Schweizer J., Salter M.W., Wang Y.T., Tasker R.A., Garman D., Rabinowitz J., Lu P.S., Tymianski M. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J. Neurosci. 2007, 27:9901-9915.
29. Dallas M., Boycott H.E., Atkinson L., Miller A., Boyle J.P., Pearson H.A., Peers C. Hypoxia suppresses glutamate transport in astrocytes. J. Neurosci. 2007, 27:3946-3955.
30. Dave K.R., DeFazio R.A., Raval A.P., Torraco A., Saul I., Barrientos A., Perez-Pinzon M.A. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J. Neurosci. 2008, 28:4172-4182.
31. Dewilde S., Kiger L., Burmester T., Hankeln T., Baudin-Creuza V., Aerts T., Marden M.C., Caubergs R., Moens L. Biochemical characterization and ligand binding properties of neuroglobin, a novel member of the globin family. J. Biol. Chem. 2001, 276:38949-38955.
32. Di G.C., Bianchi G., Cacchio M., Artese L., Piccirilli M., Verratti V., Valerio R., Iturriaga R. Neuroglobin, a new oxygen binding protein is present in the carotid body and increases after chronic intermittent hypoxia. Adv. Exp. Med. Biol. 2006, 580:15-19.
33. Dietz G.P.H. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechnol. 2010, 11:167-174.
34. Dietz G.P.H., Bähr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 2004, 27:85-131.
35. Dietz G.P.H., Bähr M. Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res. Bull. 2005, 68:103-114.
36. L protects cerebellar granule neurons against the late phase, but not against the early phase of glutamate-induced cell death. Brain Res. 2007, 1164:136-141.
37. L protein in vitro and in vivo. Neurochemistry Winter Conference. Sölden, Ötztal, Austria 2001, Ref Type: Conference Proceeding.
38. Dietz G.P.H., Kilic E., Bähr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 2002, 21:29-37.
39. Dietz, G. P. H., Kilic, E., Hofmann, E., Bähr, M. Inhibition of apoptosis by transduction of Tat-Bcl-xL protein into cerebellar granule cells. 88., 2000. Villa Gualino, Turin, Italy. Ref Type: Conference Proceeding.
40. Doeppner T.R., Dietz G.P., El A.M., Gerber J., Witte O.W., Bahr M., Weise J. TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia. Neurobiol. Dis. 2009, 34:87-94.
41. Doeppner T.R., Dietz G.P., Weise J., Bahr M. Protection of hippocampal neurogenesis by TAT-Bcl-x(L) after cerebral ischemia in mice. Exp. Neurol. 2010, 223:548-556.
42. Doeppner T.R., El A.M., Dietz G.P.H., Weise J., Schwarting S., Bähr M. Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke. Neurobiol. Dis. 2010, 40:265-276.
43. Doeppner T.R., Nagel F., Dietz G.P.H., Weise J., Tonges L., Schwarting S., Bahr M. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2009, 29:1187-1196.
44. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
45. Donnini S., Solito R., Monti M., Balduini W., Carloni S., Cimino M., Bampton E.T., Pinon L.G., Nicotera P., Thorpe P.E., Ziche M. Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4. Cell Cycle 2009, 8:1271-1278.
46. Duong T.T., Witting P.K., Antao S.T., Parry S.N., Kennerson M., Lai B., Vogt S., Lay P.A., Harris H.H. Multiple protective activities of neuroglobin in cultured neuronal cells exposed to hypoxia re-oxygenation injury. J. Neurochem. 2009, 108:1143-1154.
47. Emara M., Salloum N., lalunis-Turner J. Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells. Mol. Oncol. 2009, 3:45-53.
48. Eum W.S., Won Kim D., Koo Hwang I., Yoo K.Y., Kang T.C., Ho Jang S., Soon Choi H., Hyun Choi S., Hoon Kim Y., Young Kim S., Yil Kwon H., Hoon Kang J., Kwon O.S., Cho S.W., Soo Lee K., Park J., Ho Won M., Young Choi S. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 2004, 37:1656-1669.
49. Fago A., Hundahl C., Malte H., Weber R.E. Functional properties of neuroglobin and cytoglobin. Insights into the ancestral physiological roles of globins. IUBMB Life 2004, 56:689-696.
50. Fago A., Mathews A.J., Brittain T. A role for neuroglobin: resetting the trigger level for apoptosis in neuronal and retinal cells. IUBMB Life 2008, 60:398-401.
51. Fan Y., Shi L., Gu Y., Zhao Y., Xie J., Qiao J., Yang G.Y., Wang Y., Lu C.Z. Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion. J. Cereb. Blood Flow Metab. 2007, 27:719-728.
52. Fan Y.F., Lu C.Z., Xie J., Zhao Y.X., Yang G.Y. Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP). Neurochem. Int. 2006, 48:50-59.
53. Fordel E., Geuens E., Dewilde S., Rottiers P., Carmeliet P., Grooten J., Moens L. Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004, 319:342-348.
54. Fordel E., Thijs L., Martinet W., Lenjou M., Laufs T., Van B.D., Moens L., Dewilde S. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci. Lett. 2006, 410:146-151.
55. Fordel E., Thijs L., Martinet W., Schrijvers D., Moens L., Dewilde S. Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions. Gene 2007, 398:114-122.
56. Fordel E., Thijs L., Moens L., Dewilde S. Neuroglobin and cytoglobin expression in mice. Evidence for a correlation with reactive oxygen species scavenging. FEBS J. 2007, 274:1312-1317.
57. Fu A., Hui E.K., Lu J.Z., Boado R.J., Pardridge W.M. Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein. Brain Res. 2011, 1369:203-207.
58. Fu A., Hui E.K., Lu J.Z., Boado R.J., Pardridge W.M. Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein. Brain Res. 2010, 1360:193-197.
59. Gao Y., Liang W., Hu X., Zhang W., Stetler R.A., Vosler P., Cao G., Chen J. Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway. Stroke 2010, 41:166-172.
60. Garry D.J., Mammen P.P. Neuroprotection and the role of neuroglobin. Lancet 2003, 362:342-343.
61. Geuens E., Brouns I., Flamez D., Dewilde S., Timmermans J.P., Moens L. A globin in the nucleus!. J. Biol. Chem. 2003, 278:30417-30420.
62. Giuffre A., Moschetti T., Vallone B., Brunori M. Is neuroglobin a signal transducer?. IUBMB Life 2008, 60:410-413.
63. Gou X., Wang Q., Yang Q., Xu L., Xiong L. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. J. Drug Target. 2011, 19:86-95.
64. Greco O., Joiner M.C., Doleh A., Scott S.D. VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions. Gene Ther. 2005, 12:974-979.
65. Greig J.A., Shirley R., Graham D., Denby L., Dominiczak A.F., Work L.M., Baker A.H. Vascular-targeting anti-oxidant therapy in a model of hypertension and stroke. J. Cardiovasc. Pharmacol. 2010, 56(6):642-650.
66. Guan Q.H., Pei D.S., Zong Y.Y., Xu T.L., Zhang G.Y. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 2006, 139:609-627.
67. Guégan C., Braudeau J., Couriaud C., Dietz G.P.H., Lacombe P., Bähr M., Nosten-Bertrand M., Onténiente B. PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms. Neurobiol. Dis. 2006, 22:177-186.
68. Hachinski V., Donnan G.A., Gorelick P.B., Hacke W., Cramer S.C., Kaste M., Fisher M., Brainin M., Buchan A.M., Lo E.H., Skolnick B.E., Furie K.L., Hankey G.J., Kivipelto M., Morris J., Rothwell P.M., Sacco R.L., Smith S.C., Wang Y., Bryer A., Ford G.A., Iadecola C., Martins S.C., Saver J., Skvortsova V., Bayley M., Bednar M.M., Duncan P., Enney L., Finklestein S., Jones T.A., Kalra L., Kleim J., Nitkin R., Teasell R., Weiller C., Desai B., Goldberg M.P., Heiss W.D., Saarelma O., Schwamm L.H., Shinohara Y., Trivedi B., Wahlgren N., Wong L.K., Hakim A., Norrving B., Prudhomme S., Bornstein N.M., Davis S.M., Goldstein L.B., Leys D., Tuomilehto J. Stroke: working toward a prioritized world agenda. Stroke 2010, 41:1084-1099.
69. Hachinski V., Donnan G.A., Gorelick P.B., Hacke W., Cramer S.C., Kaste M., Fisher M., Brainin M., Buchan A.M., Lo E.H., Skolnick B.E., Furie K.L., Hankey G.J., Kivipelto M., Morris J., Rothwell P.M., Sacco R.L., Smith S.C., Wang Y., Bryer A., Ford G.A., Iadecola C., Martins S.C., Saver J., Skvortsova V., Bayley M., Bednar M.M., Duncan P., Enney L., Finklestein S., Jones T.A., Kalra L., Kleim J., Nitkin R., Teasell R., Weiller C., Desai B., Goldberg M.P., Heiss W.D., Saarelma O., Schwamm L.H., Shinohara Y., Trivedi B., Wahlgren N., Wong L.K., Hakim A., Norrving B., Prudhomme S., Bornstein N.M., Davis S.M., Goldstein L.B., Leys D., Tuomilehto J. Stroke: working toward a prioritized world agenda. Cerebrovasc. Dis. 2010, 30:127-147.
70. Hamacher-Brady A., Brady N.R., Logue S.E., Sayen M.R., Jinno M., Kirshenbaum L.A., Gottlieb R.A., Gustafsson A.B. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 2007, 14:146-157.
71. Hata R., Maeda K., Hermann D., Mies G., Hossmann K.A. Evolution of brain infarction after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2000, 20:937-946.
72. Hermann D.M., Kilic E., Hata R., Hossmann K.A., Mies G. Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience 2001, 104:947-955.
73. Herold S., Fago A., Weber R.E., Dewilde S., Moens L. Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress. J. Biol. Chem. 2004, 279:22841-22847.
74. Huang C., Yitzhaki S., Perry C.N., Liu W., Giricz Z., Mentzer R.M., Gottlieb R.A. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Transl. Res. 2010, 3:365-373.
75. Hundahl C., Kelsen J., Kjaer K., Ronn L.C., Weber R.E., Geuens E., Hay-Schmidt A., Nyengaard J.R. Does neuroglobin protect neurons from ischemic insult? A quantitative investigation of neuroglobin expression following transient MCAo in spontaneously hypertensive rats. Brain Res. 2006, 1085:19-27.
76. Hundahl C., Stoltenberg M., Fago A., Weber R.E., Dewilde S., Fordel E., Danscher G. Effects of short-term hypoxia on neuroglobin levels and localization in mouse brain tissues. Neuropathol. Appl. Neurobiol. 2005, 31:610-617.
77. Hundahl C.A., Allen G.C., Hannibal J., Kjaer K., Rehfeld J.F., Dewilde S., Nyengaard J.R., Kelsen J., Hay-Schmidt A. Anatomical characterization of cytoglobin and neuroglobin mRNA and protein expression in the mouse brain. Brain Res. 2010, 1331:58-73.
78. Hundahl C.A., Allen G.C., Nyengaard J.R., Dewilde S., Carter B.D., Kelsen J., Hay-Schmidt A. Neuroglobin in the rat brain: localization. Neuroendocrinology 2008, 88:173-182.
79. Hundahl C.A., Hannibal J., Fahrenkrug J., Dewilde S., Hay-Schmidt A. Neuroglobin expression in the rat suprachiasmatic nucleus: colocalization, innervation, and response to light. J. Comp. Neurol. 2010, 518:1556-1569.
80. Hundahl C.A., Kelsen J., Dewilde S., Hay-Schmidt A. Neuroglobin in the rat brain (II): co-localisation with neurotransmitters. Neuroendocrinology 2008, 88:183-198.
81. Hwang I.K., Yoo K.Y., Kim D.W., Kim S.Y., Park J.H., Ryoo Z.Y., Kim J., Choi S.Y., Won M.H. Ischemia-induced ribosomal protein S3 expressional changes and the neuroprotective effect against experimental cerebral ischemic damage. J. Neurosci. Res. 2008, 86:1823-1835.
82. Inagaki K., Begley R., Ikeno F., Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 2005, 111:44-50.
83. Jin K., Mao X.O., Xie L., Khan A.A., Greenberg D.A. Neuroglobin protects against nitric oxide toxicity. Neurosci. Lett. 2008, 430:135-137.
84. Jin K., Mao Y., Mao X., Xie L., Greenberg D.A. Neuroglobin expression in ischemic stroke. Stroke 2010, 41:557-559.
85. Katsura K., Takahashi K., Asoh S., Watanabe M., Sakurazawa M., Ohsawa I., Mori T., Igarashi H., Ohkubo S., Katayama Y., Ohta S. Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat. J. Neurochem. 2008, 106:258-270.
86. Khan A.A., Mao X.O., Banwait S., DerMardirossian C.M., Bokoch G.M., Jin K., Greenberg D.A. Regulation of hypoxic neuronal death signaling by neuroglobin. FASEB J. 2008, 22:1737-1747.
87. Khan A.A., Mao X.O., Banwait S., Jin K., Greenberg D.A. Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19114-19119.
88. Khan A.A., Sun Y., Jin K., Mao X.O., Chen S., Ellerby L.M., Greenberg D.A. A neuroglobin-overexpressing transgenic mouse. Gene 2007, 398:172-176.
89. Khan A.A., Wang Y., Sun Y., Mao X.O., Xie L., Miles E., Graboski J., Chen S., Ellerby L.M., Jin K., Greenberg D.A. Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17944-17948.
90. L is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 2002, 52:617-622.
91. Kilic, E., Dietz, G. P. H., Hofmann, E., Bähr, M. Effects of Tat-Bcl-xL protein after the focal brain ischemia and reperfusion injury in mice. 88., 2000. Villa Gualino, Turin, Italy. Ref Type: Conference Proceeding.
92. Kilic Ü., Kilic E., Dietz G.P.H., Bähr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 2003, 34:1304-1310.
93. Kim D.W., Eum W.S., Jang S.H., Kim S.Y., Choi H.S., Choi S.H., An J.J., Lee S.H., Lee K.S., Han K., Kang T.C., Won M.H., Kang J.H., Kwon O.S., Cho S.W., Kim T.Y., Park J., Choi S.Y. Transduced Tat-SOD fusion protein protects against ischemic brain injury. Mol. Cells 2005, 19:88-96.
94. Kim D.W., Jeong H.J., Kang H.W., Shin M.J., Sohn E.J., Kim M.J., Ahn E.H., An J.J., Jang S.H., Yoo K.Y., Won M.H., Kang T.C., Hwang I.K., Kwon O.S., Cho S.W., Park J., Eum W.S., Choi S.Y. Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic. Biol. Med. 2009, 47:941-952.
95. Kim D.W., Lee S.H., Jeong M.S., Sohn E.J., Kim M.J., Jeong H.J., An J.J., Jang S.H., Won M.H., Hwang I.K., Cho S.W., Kang T.C., Lee K.S., Park J., Yoo K.Y., Eum W.S., Choi S.Y. Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult. Free Radic. Biol. Med. 2010, 48:969-977.
96. Ko Y.T., Hartner W.C., Kale A., Torchilin V.P. Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther. 2009, 16:52-59.
97. Koerner I.P., Jacks R., DeBarber A.E., Koop D., Mao P., Grant D.F., Alkayed N.J. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J. Neurosci. 2007, 27:4642-4649.
98. Korzick D.H., Kostyak J.C., Hunter J.C., Saupe K.W. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2056-H2063.
99. Kwon J.H., Kim J.B., Lee K.H., Kang S.M., Chung N., Jang Y., Chung J.H. Protective effect of heat shock protein 27 using protein transduction domain-mediated delivery on ischemia/reperfusion heart injury. Biochem. Biophys. Res. Commun. 2007, 363:399-404.
100. la-Morte D., Raval A.P., Dave K.R., Lin H.W., Perez-Pinzon M.A. Post-ischemic activation of protein kinase C epsilon protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flow. Neurosci. Lett. 2011, 487:158-162.
101. Lechauve C., Rezaei H., Celier C., Kiger L., Corral-Debrinski M., Noinville S., Chauvierre C., Hamdane D., Pato C., Marden M.C. Neuroglobin and prion cellular localization: investigation of a potential interaction. J. Mol. Biol. 2009, 388:968-977.
102. Lee J., Tan C.Y., Lee S.K., Kim Y.H., Lee K.Y. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J. Control. Release 2009, 137:196-202.
103. Li R.C., Guo S.Z., Lee S.K., Gozal D. Neuroglobin protects neurons against oxidative stress in global ischemia. J. Cereb. Blood Flow Metab. 2010, 30:1874-1882.
104. Li R.C., Lee S.K., Pouranfar F., Brittian K.R., Clair H.B., Row B.W., Wang Y., Gozal D. Hypoxia differentially regulates the expression of neuroglobin and cytoglobin in rat brain. Brain Res. 2006, 1096:173-179.
105. Li R.C., Morris M.W., Lee S.K., Pouranfar F., Wang Y., Gozal D. Neuroglobin protects PC12 cells against oxidative stress. Brain Res. 2008, 1190:159-166.
106. Li R.C., Pouranfar F., Lee S.K., Morris M.W., Wang Y., Gozal D. Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury. Neurobiol. Aging 2008, 29:1815-1822.
107. Lin Y., Fang L., Xue X.H., Murong S.X., Wang N., Wu Z.Y. Association between Ngb polymorphisms and ischemic stroke in the Southern Chinese Han population. BMC Med. Genet. 2008, 9:110.
108. Liu C., Sun S.Q., Yu J.B., Wang K.J., Xu Q., Chen H., Li J. Expression of neuroglobin in rats with brain injury induced by LPS. Zhonghua Shao Shang Za Zhi 2009, 25:222-226.
109. Liu H., Li W., Ahmad M., Miller T.M., Rose M.E., Poloyac S.M., Uechi G., Balasubramani M., Hickey R.W., Graham S.H. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiol. Dis. 2011, 41:318-328.
110. Liu J., Yu Z., Guo S., Lee S.R., Xing C., Zhang C., Gao Y., Nicholls D.G., Lo E.H., Wang X. Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons. J. Neurosci. Res. 2009, 87:164-170.
111. Lloyd-Jones D., Adams R., Carnethon M., De S.G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
112. Lopez I.A., Acuna D., Shahram Y., Mowlds D., Ngan A.M., Rungvivatjarus T., Sharma Y., Edmond J. Neuroglobin expression in the cochlea of rat pups exposed to chronic very mild carbon monoxide (25ppm) in air during and after the prenatal period. Brain Res. 2010, 1327:56-68.
113. Luo Y., Kuo C.C., Shen H., Chou J., Greig N.H., Hoffer B.J., Wang Y. Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann. Neurol. 2009, 65:520-530.
114. Ma J., Lau C.K., Obed A., Dada A., Doenecke A., Fan S.T., Schlitt H.J., Tsui T.Y. A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury. Gene Ther. 2009, 16:320-328.
115. Mammen P.P., Shelton J.M., Goetsch S.C., Williams S.C., Richardson J.A., Garry M.G., Garry D.J. Neuroglobin, a novel member of the globin family, is expressed in focal regions of the brain. J. Histochem. Cytochem. 2002, 50:1591-1598.
116. Mendoza V., Klein D., Ichii H., Ribeiro M.M., Ricordi C., Hankeln T., Burmester T., Pastori R.L. Protection of islets in culture by delivery of oxygen binding neuroglobin via protein transduction. Transplant. Proc. 2005, 37:237-240.
117. Milton S.L., Nayak G., Lutz P.L., Prentice H.M. Gene transcription of neuroglobin is upregulated by hypoxia and anoxia in the brain of the anoxia-tolerant turtle Trachemys scripta. J. Biomed. Sci. 2006, 13:509-514.
118. Moens L., Dewilde S. Globins in the brain. Nature 2000, 407:461-462.
119. Morioka M., Kawano T., Yano S., Kai Y., Tsuiki H., Yoshinaga Y., Matsumoto J., Maeda T., Hamada J., Yamamoto H., Fukunaga K., Kuratsu J. Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Biochem. Biophys. Res. Commun. 2006, 347:273-278.
120. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
121. Myrberg H., Zhang L., Mae M., Langel U. Design of a tumor-homing cell-penetrating peptide. Bioconjug. Chem. 2008, 19:70-75.
122. Nagai S., Asoh S., Kobayashi Y., Shidara Y., Mori T., Suzuki M., Moriyama Y., Ohta S. Protection of hepatic cells from apoptosis induced by ischemia/reperfusion injury by protein therapeutics. Hepatol. Res. 2007, 37:133-142.
123. Nagel F., Dohm C.P., Bahr M., Wouters F.S., Dietz G.P.H. Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70. J. Neurosci. Methods 2008, 171:226-232.
124. Nagel F., Falkenburger B.H., Tonges L., Kowsky S., Poppelmeyer C., Schulz J.B., Bähr M., Dietz G.P.H. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. J. Neurochem. 2008, 105:853-864.
125. Nayak G., Prentice H.M., Milton S.L. Role of neuroglobin in regulating reactive oxygen species in the brain of the anoxia-tolerant turtle Trachemys scripta. J. Neurochem. 2009, 110:603-612.
126. Nguyen H.V., Chen J.L., Zhong J., Kim K.J., Crandall E.D., Borok Z., Chen Y., Ann D.K. SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells. Am. J. Pathol. 2006, 168:1452-1463.
127. Nguyen Q.T., Olson E.S., Aguilera T.A., Jiang T., Scadeng M., Ellies L.G., Tsien R.Y. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4317-4322.
128. Nguyen T.T., Ogbi M., Yu Q., Johnson J.A. Attenuation of the hypoxia-induced protein kinase Cdelta interaction with the 'd' subunit of F1Fo-ATP synthase in neonatal cardiac myocytes: implications for energy preservation and survival. Biochem. J. 2010, 429:335-345.
129. Nicolis S., Monzani E., Ciaccio C., Ascenzi P., Moens L., Casella L. Reactivity and endogenous modification by nitrite and hydrogen peroxide: does human neuroglobin act only as a scavenger?. Biochem. J. 2007, 407:89-99.
130. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van B.F., Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008, 39:2129-2137.
131. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van B.F., Kavelaars A. A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008, 39:2578-2586.
132. Nijboer C.H., Heijnen C.J., Groenendaal F., van B.F., Kavelaars A. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke 2009, 40:3362-3368.
133. Nijboer C.H., van der Kooij M.A., van B.F., Ohl F., Heijnen C.J., Kavelaars A. Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury. Brain Behav. Immun. 2010, 24:812-821.
134. Ono M., Sawa Y., Ryugo M., Alechine A.N., Shimizu S., Sugioka R., Tsujimoto Y., Matsuda H. BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury through anti-apoptotic mechanism in rat hearts. Eur. J. Cardiothorac. Surg. 2005, 27:117-121.
135. Pachori A.S., Custer L., Hansen D., Clapp S., Kemppa E., Klingensmith J. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. J. Mol. Cell. Cardiol. 2010, 48:1255-1265.
136. Pardridge W.M. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins. Adv. Exp. Med. Biol. 2002, 513:397-430.
137. Peroni D., Negro A., Bähr M., Dietz G.P.H. Intracellular delivery of neuroglobin using HIV-1 TAT protein transduction domain fails to protect against oxygen and glucose deprivation. Neurosci. Lett. 2007, 421:110-114.
138. Pileggi A., Fenjves E.S., Klein D., Ricordi C., Pastori R.L. Protecting pancreatic beta-cells. IUBMB Life 2004, 56:387-394.
139. Prieto D., Kaminski P.M., Bagi Z., Ahmad M., Wolin M.S. Hypoxic relaxation of penile arteries: involvement of endothelial nitric oxide and modulation by reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H915-H924.
140. Qin Z.H., Wang Y., Nakai M., Chase T.N. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 1998, 53:33-42.
141. Rajendram R., Rao N.A. Neuroglobin in normal retina and retina from eyes with advanced glaucoma. Br. J. Ophthalmol. 2007, 91:663-666.
142. Raychaudhuri S., Skommer J., Henty K., Birch N., Brittain T. Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell death. Apoptosis 2010, 15:401-411.
143. Rayner B.S., Duong T.T., Myers S.J., Witting P.K. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 2006, 97:211-221.
144. Repici M., Centeno C., Tomasi S., Forloni G., Bonny C., Vercelli A., Borsello T. Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation. Neuroscience 2007, 150:40-49.
145. Reuss S., Saaler-Reinhardt S., Weich B., Wystub S., Reuss M.H., Burmester T., Hankeln T. Expression analysis of neuroglobin mRNA in rodent tissues. Neuroscience 2002, 115:645-656.
146. Roesner A., Mitz S.A., Hankeln T., Burmester T. Globins and hypoxia adaptation in the goldfish, Carassius auratus. FEBS J. 2008, 275:3633-3643.
147. Ruscher K., Shamloo M., Rickhag M., Ladunga I., Soriano L., Gisselsson L., Toresson H., Ruslim-Litrus L., Oksenberg D., Urfer R., Johansson B.B., Nikolich K., Wieloch T. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 2011, 134:732-746.
148. Schmidt M., Giessl A., Laufs T., Hankeln T., Wolfrum U., Burmester T. How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. J. Biol. Chem. 2003, 278:1932-1935.
149. Schmidt-Kastner R., Haberkamp M., Schmitz C., Hankeln T., Burmester T. Neuroglobin mRNA expression after transient global brain ischemia and prolonged hypoxia in cell culture. Brain Res. 2006, 1103:173-180.
150. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
151. Shang A., Zhou D., Wang L., Gao Y., Fan M., Wang X., Zhou R., Zhang C. Increased neuroglobin levels in the cerebral cortex and serum after ischemia-reperfusion insults. Brain Res. 2006, 1078:219-226.
152. Shao G., Gong K.R., Li J., Xu X.J., Gao C.Y., Zeng X.Z., Lu G.W., Huo X. Antihypoxic effects of neuroglobin in hypoxia-preconditioned mice and SH-SY5Y cells. Neurosignals 2009, 17:196-202.
153. Song B.W., Vinters H.V., Wu D., Pardridge W.M. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J. Pharmacol. Exp. Ther. 2002, 301:605-610.
154. Souktani R., Pons S., Guegan C., Bouhidel O., Bruneval P., Zini R., Mandet C., Onteniente B., Berdeaux A., Ghaleh B. Cardioprotection against myocardial infarction with PTD-BIR3/RING, a XIAP mimicking protein. J. Mol. Cell. Cardiol. 2009, 46:713-718.
155. Sun H.S., Doucette T.A., Liu Y., Fang Y., Teves L., Aarts M., Ryan C.L., Bernard P.B., Lau A., Forder J.P., Salter M.W., Wang Y.T., Tasker R.A., Tymianski M. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke 2008, 39:2544-2553.
156. Sun Y., Jin K., Mao X.O., Xie L., Peel A., Childs J.T., Logvinova A., Wang X., Greenberg D.A. Effect of aging on neuroglobin expression in rodent brain. Neurobiol. Aging 2005, 26:275-278.
157. Sun Y., Jin K., Mao X.O., Zhu Y., Greenberg D.A. Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15306-15311.
158. Sun Y., Jin K., Peel A., Mao X.O., Xie L., Greenberg D.A. Neuroglobin protects the brain from experimental stroke in vivo. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3497-3500.
159. Suzuki T., Zhang Y., Zhang Y.F., Schlachetzki F., Pardridge W.M. Imaging gene expression in regional brain ischemia in vivo with a targeted [111in]-antisense radiopharmaceutical. Mol. Imaging 2004, 3:356-363.
160. Tang Y., Shao Y., Su J., Zhou H., Liu L., Ren H., Dong Q. The protein therapy of kallikrein in cerebral ischemic reperfusion injury. Curr. Med. Chem. 2009, 16:4502-4510.
161. van der Kooij M.A., Nijboer C.H., Ohl F., Groenendaal F., Heijnen C.J., van B.F., Kavelaars A. NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiol. Dis. 2010, 38:266-272.
162. Vaslin A., Puyal J., Clarke P.G. Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia. Ann. Neurol. 2009, 65:337-347.
163. Verratti V., Di G.C., Bianchi G., Cacchio M., Petruccelli G., Artese L., Lahiri S., Iturriaga R. Neuroglobin in aging carotid bodies. Adv. Exp. Med. Biol. 2009, 648:191-195.
164. Wang Q., Gou X., Xiong L., Jin W., Chen S., Hou L., Xu L. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 2008, 108:1071-1080.
165. Wang X., Liu J., Zhu H., Tejima E., Tsuji K., Murata Y., Atochin D.N., Huang P.L., Zhang C., Lo E.H. Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia. Stroke 2008, 39:1869-1874.
166. Watanabe S., Wakasugi K. Neuroprotective function of human neuroglobin is correlated with its guanine nucleotide dissociation inhibitor activity. Biochem. Biophys. Res. Commun. 2008, 369:695-700.
167. Watanabe S., Wakasugi K. Zebrafish neuroglobin is a cell-membrane-penetrating globin. Biochemistry 2008, 47:5266-5270.
168. Watanabe S., Wakasugi K. Identification of residues critical for the cell-membrane-penetrating activity of zebrafish neuroglobin. FEBS Lett. 2010, 584:2467-2472.
169. Wei X., Miou Z., Baudry M. Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences. Neuroscientist 2008, 14:409-414.
170. Wei Y., Yemisci M., Kim H.H., Yung L.M., Shin H.K., Hwang S.K., Guo S., Qin T., Alsharif N., Brinkmann V., Liao J.K., Lo E.H., Waeber C. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 2011, 69:119-129.
171. Wiegler K., Bonny C., Coquoz D., Hirt L. The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator. Cerebrovasc. Dis. 2008, 26:360-366.
172. Williams T.M., Zavanelli M., Miller M.A., Goldbeck R.A., Morledge M., Casper D., Pabst D.A., McLellan W., Cantin L.P., Kliger D.S. Running, swimming and diving modifies neuroprotecting globins in the mammalian brain. Proc. Biol. Sci. 2008, 275:751-758.
173. Won Y.W., Kim J.K., Cha M.J., Hwang K.C., Choi D., Kim Y.H. Prolongation and enhancement of the anti-apoptotic effects of PTD-Hsp27 fusion proteins using an injectable thermo-reversible gel in a rat myocardial infarction model. J. Control. Release 2010, 144:181-189.
174. Wu A.P., Whitney M.A., Crisp J.L., Friedman B., Tsien R.Y., Nguyen Q.T. Improved facial nerve identification with novel fluorescently labeled probe. Laryngoscope 2011, 121:805-810.
175. Wystub S., Laufs T., Schmidt M., Burmester T., Maas U., Saaler-Reinhardt S., Hankeln T., Reuss S. Localization of neuroglobin protein in the mouse brain. Neurosci. Lett. 2003, 346:114-116.
176. Ye S.Q., Zhou X.Y., Lai X.J., Zheng L., Chen X.Q. Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3gamma. Acta Pharmacol. Sin. 2009, 30:913-918.
177. Yin W., Cao G., Johnnides M.J., Signore A.P., Luo Y., Hickey R.W., Chen J. TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol. Dis. 2006, 21:358-371.
178. Yu C.Z., Li C., Pei D.S., Zong Y.Y., Shi Q., Wen X.R., Guan Q.H., Hang D., Hou X.Y., Zhang G.Y. Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction. Neurochem. Res. 2009, 34:2008-2021.
179. Yu Z., Liu J., Guo S., Xing C., Fan X., Ning M., Yuan J.C., Lo E.H., Wang X. Neuroglobin-overexpression alters hypoxic response gene expression in primary neuron culture following oxygen glucose deprivation. Neuroscience 2009, 162:396-403.
180. Zhang C., Wang C., Deng M., Li L., Wang H., Fan M., Xu W., Meng F., Qian L., He F. Full-length cDNA cloning of human neuroglobin and tissue expression of rat neuroglobin. Biochem. Biophys. Res. Commun. 2002, 290:1411-1419.
181. Zhang F., Xing J., Liou A.K., Wang S., Gan Y., Luo Y., Ji X., Stetler R.A., Chen J., Cao G. Enhanced delivery of erythropoietin across the blood-brain barrier for neuroprotection against ischemic neuronal injury. Transl. Stroke Res. 2010, 1:113-121.
182. Zhang Q.X., Pei D.S., Guan Q.H., Sun Y.F., Liu X.M., Zhang G.Y. Blockade of the translocation and activation of mitogen-activated protein kinase kinase 4 (MKK4) signaling attenuates neuronal damage during later ischemia-reperfusion. J. Neurochem. 2006, 98:170-179.
183. Zhang Q.X., Pei D.S., Guan Q.H., Sun Y.F., Liu X.M., Zhang G.Y. Crosstalk between PSD-95 and JIP1-mediated signaling modules: the mechanism of MLK3 activation in cerebral ischemia. Biochemistry 2007, 46:4006-4016.
184. Zhang Y.E., Wang J.N., Tang J.M., Guo L.Y., Yang J.Y., Huang Y.Z., Tan Y., Fu S.Z., Kong X., Zheng F. In vivo protein transduction: delivery of PEP-1-SOD1 fusion protein into myocardium efficiently protects against ischemic insult. Mol. Cells 2009, 27:159-166.
185. Zhou G.Y., Zhou S.N., Lou Z.Y., Zhu C.S., Zheng X.P., Hu X.Q. Translocation and neuroprotective properties of transactivator-of-transcription protein-transduction domain-neuroglobin fusion protein in primary cultured cortical neurons. Biotechnol. Appl. Biochem. 2008, 49:25-33.
186. Zhou L., Li F., Xu H.B., Luo C.X., Wu H.Y., Zhu M.M., Lu W., Ji X., Zhou Q.G., Zhu D.Y. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat. Med. 2010, 16:1439-1443.
187. Zhou M., Xu W., Liao G., Bi X., Baudry M. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp. Neurol. 2009, 218:75-82.